世界の呼吸器疾患用LAMP（ループ介在等温増幅）技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3354 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、呼吸器疾患用LAMP（ループ介在等温増幅）技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（マイコプラズマ・ニューモニアエ、ストレプトコッカス・ニューモニアエ、インフルエンザ菌、モラクセラ・カタラーリス、クラミジア肺炎、クレブシエラ肺炎、黄色ブドウ球菌、その他）、用途別市場規模（乳幼児（1歳以下）、小児・青年（1〜25歳）、成人（25〜65歳）、高齢者（65歳以上））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の市場動向 ・企業の競争状況、市場シェア ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の種類別市場規模（マイコプラズマ・ニューモニアエ、ストレプトコッカス・ニューモニアエ、インフルエンザ菌、モラクセラ・カタラーリス、クラミジア肺炎、クレブシエラ肺炎、黄色ブドウ球菌、その他） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の用途別市場規模（乳幼児（1歳以下）、小児・青年（1〜25歳）、成人（25〜65歳）、高齢者（65歳以上）） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器疾患用LAMP（ループ介在等温増幅）技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CapitalBio、BGI、Eiken Chemical、Deaou Biotechnology、Singuway、New England Biolabs、Lucigen Corporation、Merck、Mast Group、OptiGene、CapitalBio、Weifang Kanghua Biotech Co.,Ltd、CapitalBio、BGI） ・結論

Market Analysis and Insights: Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
The global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market.

Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Scope and Market Size
LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Pathogene
Mycoplasma Pneumoniae
Streptococcus Pneumoniae
Haemophilus Influenzae
Moraxella Catarrhalis
Chlamydia Pneumoniae
Klebsiella Pneumoniae
Staphylococcus Aureus
Others
by Disease
Cold
Pharyngitis
Bronchitis
Tracheitis
Pneumonia (Covid-19, CAP, etc.)

Segment by Application
Infant (<1 year old) Children and Adolescents (1-25 years old) Adult (25-65 years old) Senior citizens (over 65 years old) By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company CapitalBio BGI Eiken Chemical Deaou Biotechnology Singuway New England Biolabs Lucigen Corporation Merck Mast Group OptiGene CapitalBio Weifang Kanghua Biotech Co.,Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mycoplasma Pneumoniae
1.2.3 Streptococcus Pneumoniae
1.2.4 Haemophilus Influenzae
1.2.5 Moraxella Catarrhalis
1.2.6 Chlamydia Pneumoniae
1.2.7 Klebsiella Pneumoniae
1.2.8 Staphylococcus Aureus
1.2.9 Others
1.3 Market by Application
1.3.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infant (<1 year old) 1.3.3 Children and Adolescents (1-25 years old) 1.3.4 Adult (25-65 years old) 1.3.5 Senior citizens (over 65 years old) 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Perspective (2016-2027) 2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Growth Trends by Regions 2.2.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Share by Regions (2016-2021) 2.2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Regions (2022-2027) 2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Industry Dynamic 2.3.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Trends 2.3.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers 2.3.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges 2.3.4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue 3.1.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue (2016-2021) 3.1.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Players (2016-2021) 3.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue 3.4 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio 3.4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2020 3.5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players Head office and Area Served 3.6 Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service 3.7 Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Type 4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Type (2016-2021) 4.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2022-2027) 5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Application 5.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Application (2016-2021) 5.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2016-2027) 6.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type 6.2.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) 6.2.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) 6.2.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2027) 6.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application 6.3.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) 6.3.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) 6.3.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2027) 6.4 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country 6.4.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) 6.4.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2016-2027) 7.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type 7.2.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) 7.2.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) 7.2.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2027) 7.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application 7.3.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) 7.3.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) 7.3.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2027) 7.4 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country 7.4.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) 7.4.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2016-2027) 8.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type 8.2.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) 8.2.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) 8.2.3 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2027) 8.3 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application 8.3.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) 8.3.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) 8.3.3 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2027) 8.4 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region 8.4.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2016-2021) 8.4.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2016-2027) 9.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type 9.2.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) 9.2.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) 9.2.3 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2027) 9.3 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application 9.3.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) 9.3.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) 9.3.3 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2027) 9.4 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country 9.4.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) 9.4.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2016-2027) 10.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type 10.2.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) 10.2.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) 10.2.3 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2027) 10.3 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application 10.3.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) 10.3.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) 10.3.3 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2027) 10.4 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country 10.4.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) 10.4.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 CapitalBio 11.1.1 CapitalBio Company Details 11.1.2 CapitalBio Business Overview 11.1.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.1.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.1.5 CapitalBio Recent Development 11.2 BGI 11.2.1 BGI Company Details 11.2.2 BGI Business Overview 11.2.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.2.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.2.5 BGI Recent Development 11.3 Eiken Chemical 11.3.1 Eiken Chemical Company Details 11.3.2 Eiken Chemical Business Overview 11.3.3 Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.3.4 Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.3.5 Eiken Chemical Recent Development 11.4 Deaou Biotechnology 11.4.1 Deaou Biotechnology Company Details 11.4.2 Deaou Biotechnology Business Overview 11.4.3 Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.4.4 Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.4.5 Deaou Biotechnology Recent Development 11.5 Singuway 11.5.1 Singuway Company Details 11.5.2 Singuway Business Overview 11.5.3 Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.5.4 Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.5.5 Singuway Recent Development 11.6 New England Biolabs 11.6.1 New England Biolabs Company Details 11.6.2 New England Biolabs Business Overview 11.6.3 New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.6.4 New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.6.5 New England Biolabs Recent Development 11.7 Lucigen Corporation 11.7.1 Lucigen Corporation Company Details 11.7.2 Lucigen Corporation Business Overview 11.7.3 Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.7.4 Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.7.5 Lucigen Corporation Recent Development 11.8 Merck 11.8.1 Merck Company Details 11.8.2 Merck Business Overview 11.8.3 Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.8.4 Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.8.5 Merck Recent Development 11.9 Mast Group 11.9.1 Mast Group Company Details 11.9.2 Mast Group Business Overview 11.9.3 Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.9.4 Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.9.5 Mast Group Recent Development 11.10 OptiGene 11.10.1 OptiGene Company Details 11.10.2 OptiGene Business Overview 11.10.3 OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.10.4 OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.10.5 OptiGene Recent Development 11.11 CapitalBio 11.11.1 CapitalBio Company Details 11.11.2 CapitalBio Business Overview 11.11.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.11.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.11.5 CapitalBio Recent Development 11.12 Weifang Kanghua Biotech Co.,Ltd 11.12.1 Weifang Kanghua Biotech Co.,Ltd Company Details 11.12.2 Weifang Kanghua Biotech Co.,Ltd Business Overview 11.12.3 Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.12.4 Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.12.5 Weifang Kanghua Biotech Co.,Ltd Recent Development 11.13 CapitalBio 11.13.1 CapitalBio Company Details 11.13.2 CapitalBio Business Overview 11.13.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.13.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.13.5 CapitalBio Recent Development 11.14 BGI 11.14.1 BGI Company Details 11.14.2 BGI Business Overview 11.14.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction 11.14.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) 11.14.5 BGI Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables
Table 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mycoplasma Pneumoniae
Table 3. Key Players of Streptococcus Pneumoniae
Table 4. Key Players of Haemophilus Influenzae
Table 5. Key Players of Moraxella Catarrhalis
Table 6. Key Players of Chlamydia Pneumoniae
Table 7. Key Players of Klebsiella Pneumoniae
Table 8. Key Players of Staphylococcus Aureus
Table 9. Key Players of Others
Table 10. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Regions (2016-2021)
Table 14. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Regions (2022-2027)
Table 16. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Trends
Table 17. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers
Table 18. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges
Table 19. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints
Table 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players (2016-2021)
Table 22. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2020)
Table 23. Ranking of Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
Table 27. Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 30. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2016-2021)
Table 31. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2016-2021)
Table 35. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2022-2027) & (US$ Million)
Table 67. CapitalBio Company Details
Table 68. CapitalBio Business Overview
Table 69. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 70. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 71. CapitalBio Recent Development
Table 72. BGI Company Details
Table 73. BGI Business Overview
Table 74. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 75. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 76. BGI Recent Development
Table 77. Eiken Chemical Company Details
Table 78. Eiken Chemical Business Overview
Table 79. Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 80. Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 81. Eiken Chemical Recent Development
Table 82. Deaou Biotechnology Company Details
Table 83. Deaou Biotechnology Business Overview
Table 84. Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 85. Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 86. Deaou Biotechnology Recent Development
Table 87. Singuway Company Details
Table 88. Singuway Business Overview
Table 89. Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 90. Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 91. Singuway Recent Development
Table 92. New England Biolabs Company Details
Table 93. New England Biolabs Business Overview
Table 94. New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 95. New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 96. New England Biolabs Recent Development
Table 97. Lucigen Corporation Company Details
Table 98. Lucigen Corporation Business Overview
Table 99. Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 100. Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 101. Lucigen Corporation Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Mast Group Company Details
Table 107. Mast Group Business Overview
Table 108. Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 109. Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 110. Mast Group Recent Development
Table 111. OptiGene Company Details
Table 112. OptiGene Business Overview
Table 113. OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 114. OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 115. OptiGene Recent Development
Table 116. CapitalBio Company Details
Table 117. CapitalBio Business Overview
Table 118. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 119. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 120. CapitalBio Recent Development
Table 121. Weifang Kanghua Biotech Co.,Ltd Company Details
Table 122. Weifang Kanghua Biotech Co.,Ltd Business Overview
Table 123. Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 124. Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 125. Weifang Kanghua Biotech Co.,Ltd Recent Development
Table 126. CapitalBio Company Details
Table 127. CapitalBio Business Overview
Table 128. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 129. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 130. CapitalBio Recent Development
Table 131. BGI Company Details
Table 132. BGI Business Overview
Table 133. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 134. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021) & (US$ Million)
Table 135. BGI Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type: 2020 VS 2027
Figure 2. Mycoplasma Pneumoniae Features
Figure 3. Streptococcus Pneumoniae Features
Figure 4. Haemophilus Influenzae Features
Figure 5. Moraxella Catarrhalis Features
Figure 6. Chlamydia Pneumoniae Features
Figure 7. Klebsiella Pneumoniae Features
Figure 8. Staphylococcus Aureus Features
Figure 9. Others Features
Figure 10. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application: 2020 VS 2027
Figure 11. Infant (<1 year old) Case Studies
Figure 12. Children and Adolescents (1-25 years old) Case Studies
Figure 13. Adult (25-65 years old) Case Studies
Figure 14. Senior citizens (over 65 years old) Case Studies
Figure 15. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Report Years Considered
Figure 16. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Regions: 2020 VS 2027
Figure 19. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Regions (2022-2027)
Figure 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players in 2020
Figure 21. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2020
Figure 22. The Top 10 and 5 Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2020
Figure 23. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2016-2021)
Figure 24. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2022-2027)
Figure 25. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type (2016-2027)
Figure 27. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application (2016-2027)
Figure 28. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2016-2027)
Figure 29. United States LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type (2016-2027)
Figure 33. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application (2016-2027)
Figure 34. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2016-2027)
Figure 35. Germany LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type (2016-2027)
Figure 43. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application (2016-2027)
Figure 44. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2016-2027)
Figure 45. China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type (2016-2027)
Figure 53. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application (2016-2027)
Figure 54. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2016-2027)
Figure 55. Mexico LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type (2016-2027)
Figure 59. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application (2016-2027)
Figure 60. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2016-2027)
Figure 61. Turkey LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 65. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 66. Eiken Chemical Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 67. Deaou Biotechnology Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 68. Singuway Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 69. New England Biolabs Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 70. Lucigen Corporation Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 71. Merck Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 72. Mast Group Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 73. OptiGene Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 74. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 75. Weifang Kanghua Biotech Co.,Ltd Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 76. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 77. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---